The effect of magnesium deficiency on glucose disposal, glucose-stimulated insulin secretion and insulin action on skeletal muscle was investigated in rats which were fed a low magnesium-containing diet for 4 days. Control rats were fed a standard diet. Compared to the control rats, the rats fed with low magnesium diet presented: 1) lower serum magnesium levels (0.45 + 0.02 vs 0.78 + 0.01 mmol/1, p < 0.001), 2) higher basal serum glucose (6.8 +__ 0.2 vs 5.5 + 0.2 mmol/1, p < 0.05) and similar basal serum insulin, 3) 40 % reduction (p < 0.001) in the glucose disappearance rate after its i.v. administration, and 4) 45 % reduction (p < 0.05) in the glucose-stimulated insulin secretion. The insulin action upon the glucose uptake by skeletal muscle was determined by means of hindquarter perfusions. Compared with control rats, magnesium-deficient rats presented: 1) normal basal glucose uptake, 2) lower stimulatory effect on the glucose uptake by insulin at the concentrations of 5 x 10 -l~ mol/1 (3.0 + 0.9 vs 5.4 + 0.6, p < 0.05) and 5 x 10 -9 tool/1 (6.3 + 0.5 vs 8.0 + 0.5, p < 0.05), 3) normal glucose uptake at a maximal insulin concentration of i x 10 .7 mol/1, and 4) 50 % reduction in the insulin sensitivity (ED50:1.3 +_ 0.3 vs 0.55 + 0.1 mol/1, p < 0.05). In partially purified insulin receptors prepared from gastrocnemius muscle, 125I-insulin binding was similar in both groups of rats. However, the autophosphorylation of the fi-subunit of the insulin receptor was significantly reduced by 50 % in magnesium-deficient rats and the tyrosine kinase activity of insulin receptors toward the exogenous substrate Poly Glu4: Tyr 1 was also reduced (p < 0.05) by hypomagnesaemia. The abundance of the insulin-sensitive glucose transporter protein (muscle/fat GLUT4), measured by Western blot analysis using polyclonal antisera, was similar in muscles of control and hypomagnesaemic rats. These findings indicate that hypomagnesaemia has a deleterious effect on glucose metabolism due to an impairment of both insulin secretion and action. The insulin resistance observed in skeletal muscle of magnesium-deficient rats may be attributed, at least in part, to a defective tyrosine kinase activity of insulin receptors.
Among the different hormones, insulin is an important modulator of the cellular content of magnesium [1, 2] , the most abundant intracellular divalent cation. Insulin-resistant patients have an impaired insulin-mediated erythrocyte magnesium accumulation [3] [4] [5] which correlates with a decrease in insulin sensitivity [3, 4] . On the other hand, magnesium is a cofactor of many enzymes involved in glucose metabolism, especially those using high energy phosphate bonds [6] . In vitro studies have shown that this cation has an important role in insulin action [1, 7] . A relation-ship between hypomagnesaemia and insulin resistance has been reported among diabetic patients [8, 9] , and furthermore, chronic administration of magnesium has been found to improve the insulin sensitivity in non-insulin-dependent diabetic subjects [10] and in patients with severe hypomagnesaemia [11] .
Insulin binding to specific cell surface receptors is the initial event in insulin action on target tissues. Insulin receptors are heteroligomeric glycoproteins consisting of two a-subunits (130-135 kDa), which bind insulin, and two/3-subunits (90-95 kDa), which possess an intrinsic tyrosine kinase activity. It has been postulated that the activation of the protein kinase of the insulin receptor is an important step in transmembrane signalling for insulin action. There are several examples where alterations in receptor kinase activity could explain an impairment of the insulin action [12] [13] [14] [15] [16] .
In this study, our aim was to investigate the effect of hypomagnesaemia on the insulin action in skeletal muscle, the major site of peripheral insulin-stimulated glucose disposal. The overall glucose disposal and the glucose-stimulated insulin secretion were also studied.
Materials and methods

Materials. Porcine monocomponent insulin (Novo Research
Institute, Copenhagen, Denmark) was used for insulin studies and iodination by the chloramine T method [17] at a specific activity of 185 gCi/~g. [y32p]-ATP (4,000 Ci/mmol) was purchased from ICN Biomedicals, ICN (Costa Mesa, Calif., USA). Wheat germ-agglutinin agarose (WGA) was prepared from lectin and cyanogen bromide-activated Sepharose 4B (Pharmacia LKB, Uppsala, Sweden). Bovine serum albumin radioimmunoassay-grade Fraction V, N-2-hydroxyethylpiperazine-N'-2-ethane sulphonic acid (Hepes), Poly Glu4:Tyrl (4:1), phenylmethylsulphonyl fluoride (PMSF), leupeptin, pepstatin, bacitracin, vanadate, sodium fluoride, 2-acetamido-2-deoxy-D-glucose (N-acetyl-D-glucosamine) and pyrophosphate were obtained from Sigma (St.Louis, Mo., USA). Aprotinin was from Boehringer Mannheim (Mannheim, Germay). Reagents for polyacrylamide gel electrophoresis and Triton X-100 were obtained from Bio-Rad Laboratories (Richmond, Calif., USA). Anti-insulin receptor antibody (AB-3) was from Oncogene Science, INC (Uniondale, N.Y., USA). All other chemicals were of analytical grade. The magnesium content in serum and in dry skeletal muscle (gastrocnemius) and serum calcium were measured by an automated atomic absorption procedure, using a Perkin-Elmer 305B spectrophotometer (Perkin-Elmer, Norwalk, Connecticut, USA). Protein determination was performed by the Bradford dye method (Bio-Rad Laboratories Richmond GmbH, Munich, Germany). Serum insulin levels were measured by radioimmunoassay [18] using rat insulin standard (Novo Research Institute). Serum glucose levels were determined by the glucose-oxidase method using a Beckman 2 Glucose Analyzer (Beckman Instruments S.A., Madrid, Spain).
Experimental animals. Experiments were performed on male albino Wistar rats weighing 180-200 g, bred in our centre. Rats were fed a diet containing low magnesium (3.8 mg/%) 1263 for 4 days; control rats were fed a standard Mg+2-containing diet (85.8 mg/%) for 4 days.
Intravenous glucose tolerance test. After a 12-h fasting period rats were anaesthetized with an i.p: injection of sodium pentothal (75 mg/kg body weight). An intravenous glucose tolerance test (IVGTr) was performed as described by Varnum et al. [19] , with minor modifications. After tracheotomy, a catheter was placed into the right common carotid artery and a basal blood sample was taken. Glucose (0.5 g/kg body weight) was then quickly injected and the catheter flushed with 0.9 % NaC1 containing heparin. Blood samples were drawn at 4, 8, 12, 16, 20 , and 30 min after injection. Serum was separated from blood cells by centrifugation and stored at -20 ~ until the glucose and the insulin contents were assayed. The glucose disappearance rate was expressed as the K index, calculated from the formula K=(0.6931/tv2 ) x 100, where tv2 is the time in minutes required to halve the glucose concentration.
Hindquarter perfusion. Male Wistar rats were fasted for 16 h before peffusion. The muscle perfusion system we used was based on the method described by Ruderman et al. [20] and modified by Dohm et al. [21] . After anaesthesia with sodium pentothal (75 mg/kg body weight, i.p.), a midline abdominal incision was made. The lower colon was ligated and excised. Internal spermatic, iliolumbar, left renal, superficial epigastric and hypogastric vessels were ligated. Loose ligatures were placed around the aorta proximal to the left renal vein and around the vena cava distal to the juction with the right renal vein. These ligatures were then quickly tightened and the animal was transected just before the last secured ligatures. The hemicorpus was transferred to the perfusion chamber (maintained at 37 ~ and cannulae were quickly inserted into the aorta and vena cava. Flow of the perfusion medium was started as soon as possible and the interruption of oxygenation of the hemicorpus was less than 2 min from the ligation of the aorta until flow was reestablished. The hemicorpus was perfused with Krebs-Henseleit solution, pH 7.4, containing 5.5 mmol/1 glucose, 0.15 mmol/1 pyruvate, 4 % bovine serum albumin (Fraction V, Sigma) and 30 % washed bovine erythr0-cytes. The flow rate was maintained at 12 ml/min. Pressure was measured by a mercury manometer connected by a side arm to the arterial tubing. After a 50-ml washout period, the perfusate (100 ml) was recirculated for the duration of the perfusion. The aortic pressure remained at 80-100 mm Hg throughout this period. The perfusion medium was oxygenated in a Silastic tube oxygenator (7 m long, 1 mm in diameter and 0.2 mm wall thickness) suspended in another tube flushed with oxygen. The hindquarters were perfused for a total of 100 rain: 25 min without insulin, 25 min with 5 x 10 -1~ mol/1 insulin, 25 min with 5 x 10 -9 tool/1 insulin and 25 min with 10 .7 mol/1 insulin. When 5 x 10 -9 and 10 .7 mol/1 insulin was added, glucose was also added to the perfusion medium to reach the initial concentration of 5.5 retool/1. Samples were taken every 5 rain for glucose assay and calculation of glucose uptake.
Insulin receptor purification. Rats were killed by cervical dislocation, and the gastrocnemius muscles were quickly removed, frozen under liquid nitrogen, and stored at -70 ~ until receptor purification was performed. Frozen muscles were powdered in liquid nitrogen, and homogenized in 50 mmol/1 Hepes buffer, pH 7.4, containing 1% Triton X-100, 50 retool/1 NaC1, 2 ~mol/1 leupeptin, 2 ~mol/1 pepstatin, i mmol/1 PMSF, 1 mg/ ml bacitracin, 1 mmol/1 vanadate, 1,000 U/1 aprotinin, 10 mmol/1 pyrophosphate, 8 mmol/1 EDTA and 100 mmol/1 NaF. The homogenate was centrifuged at 10,000 x g for 20 min at 4 ~ and the supernatant containing cellular mem-branes was solubilized by stirring at 4 ~ for 60 rain. The insoluble material was removed by centrifugation for 90 rain at 100,000 x g at 4 ~ The soluble extracts were used for preparing insulin receptors and for measuring the content of the glucose transporter GLUT 4. Partially purified insulin receptors were prepared following the method of Hedo et al. [22] . In essence, the soluble extract was incubated overnight at 4 ~ with 4 ml of WGA, and after extensive washing with 50 mmol/1 Hepes buffer (pH 7.4) containing 150 mmol/1 NaC1, 0.1 retool/1 PMSF and 0.1% Triton X-100 (WGA buffer), the bound glycoproteins including the insulin receptor were elnted using the WGA buffer with 0.3 mol/1 N-acetyl-D-glucosamine. These partially purified insulin receptor preparations were used to measure 125I-insulin binding and tyrosine-specific protein kinase activity. The amount of protein used in these assays was 15 ~g as estimated by the Bradford reaction [23] .
A. Su~irez et al.: Insulin action in hypomagnesaemia the insulin receptor was localized in the autoradiography and measured by densitometry.
Cross-linkage of solubilized insulin receptors with 12sI-insulin.
After optimal 125I-insulin binding in the absence and presence of unlabelled insulin (10 -8 and 10 -7 tool/l), equal amounts of the 125I-insulin receptor complex were covalently cross-linked with 1 retool/1 disuccinimidyl suberate for 15 min at 4 ~ using the method of Pilch and Czech [27] . The samples were suspended in Laemmli buffer with 3 % dithiothreitol and boiled for 5 min. PAGE was performed according to the method of Laemmli [26] in a 7.5 % gel. The gels were fixed, dried, and autoradiographed for 24 h at -70 ~ with Kodak X-Omat film using lighting plus screen. The electrophoretic migration of the cross-linked c~-subunit of the insulin receptor was localized in the autoradiography.
Insulin binding to purified insulin receptors. Partially purified solubilized receptors were incubated in duplicate, in a final volume of 250 ~tl of WGA buffer, in the presence of 10 -2~ mol/1 125I-insulin and in the absence or the presence of increasing concentrations of unlabelled insulin (10-1~ -6 tool/l) for 16 h at 4 ~ The t25I-insulin bound to the receptor was precipitated by the addition of 500 ~tl of 0.1% human ;e-globulin and 500 ~1 of 25 % (w/w) polyethyleneglycol and collected by centrifugation in a Beckman J-6B centrifuge (4,000 x g for 45 rain at 4 ~ The pellet was then washed with 1 ml of 12.5 % polyethyleneglycol and separated again by centrifugation. The resulting pellet was counted for gamma-radioactivity. Specific 125I-insulin binding was determined for each insulin concentration after subtracting the non-specific value obtained in the presence of 10 -6 mol/l unlabelled insulin. The degradation of 125I-insulin as determined by trichloroacetic acid precipitation was less than 10 % under the assay conditions. The binding capacity was calculated by Scatchard analysis [24] .
Tyrosine kinase activity: phosphorylation of an exogenous substraw. Insulin receptors were incubated in triplicate in the absence and presence of insulin (10 -7 tool/l) at 4 ~ for 16 h. The tyrosine-specific protein kinase activity was then determined at room temperature using the method of Grunberger et al. [25] , with minor modifications. In brief, [y32P]-ATP (2.5 ~tCi, 100 ~tmol/1) was added in the presence of 2.5 mg/ml of the exogenous substrate Poly Glu4:Tyrl, 10mmol/1 MgCI~, and 0.5 mmol/1 MnC12, in 50 mmol/1 Hepes buffer, pH 7.4. The reaction was stopped after 30 min with 10 % trichloroacetic acid containing 10 mmol/1 pyrophosphate. Reagent blanks were subtracted. Results are expressed as pmol of [32p] incorporated into Poly Glu4:Tyrl per ~tg of the receptor preparation.
Analysis of the glucose transporter protein GLUT 4. The insu-
lin-sensitive glucose transporter protein (muscle/fat GLUT 4) was measured by Western blot analysis in the solubilized material obtained from homogenates of gastrocnemius muscles. An aliquot of the soluble extract (50 ~tg protein) was mixed with 50 ~tl Laemmli sample buffer containing 5 % dithiothreitol, brought to a total volume of 100 ~tl with 25 mmol/1 Tris, 190 mmol/1 glycine, pH 8.4 containing 0.1% SDS, and left overnight at 4 ~ Proteins were separated by SDS polyacrylamide gel electrophoresis on 10 % resolving gel using Laemmli's method [26] , and transferred to Immobilon membrane by electrotransfer. The membrane was blocked for 2 h with 5 % Carnation Low-fat Instant Milk in Tris buffered saline (TBS), followed by incubation with 10 ~tg of a polyclonal antisera raised in rabbits specific for a 12-amino acid peptide based on the deduced carboxyl-terminal sequence of the GLUT 4 [28] . After a 16-h incubation at 4 ~ the membrane was washed alternatively in TBS-0.05 % Tween and probed for 3 h with 125I-goat anti-rabbit IgG. Autoradiography was carried out for 48 h at -70~
Statistical analys&
Results are given as mean + SEM. Student's t-test for unpaired data was used to evaluate the statistical significance of differences between hypomagnesaemic and control groups. Correlation coefficients were calculated by linear regression analysis. Areas under the curves were determined using the trapezoidal rule.
Insulin receptor autophosphorylation. Insulin receptors were incubated in the absence and the presence of insulin (10 -7 rnol/1) at 4~ for 16 h; then [y32p]-ATP (40 ~tCi, 50 ~tmol/1) was added in the presence of 5 mmol/1 MgC12 and 10 mmol/1 MnC12 in 50 mmol/1 Hepes buffer, pH 7.4. The reaction was terminated after 60 rain with an equal volume of 50 mmol/1 Hepes buffer containing 10 mmol/1 EDTA, 100 mmol/1 NaF, 20 mmol/1 pyrophosphate, and 4 mmol/1 ATP. The mixture was incubated for 16 h at 4 ~ with monoclonal insulin receptor antibody (AB-3) and protein A-agarose plus goat anti-mouse IgG. The immunoprecipitates were then centrifuged at 2,500 x g for 15 rain at 4 ~ and washed first with WGA buffer, then with WGA buffer containing 0.5 mmol/1 NaC1 and finally with 50 mmol/1 Hepes buffer, pH 7.4, containing 0.01% SDS. Pellets were suspended in Laemmli buffer with 3 % dithiothreitol, boiled for 5 min, and subjected to SDS polyacrylamide (7.5 %) slab gel electrophoresis [26] . The/3-subunit of
Results
Animal character&tics. After 4 days on the diet, the mean serum magnesium level was significantly lower (t7 < 0.001) in the group of hypomagnesaemic rats (0.45 + 0.02 mmol/1, range: 0.25-0.64) in comparison with that in the control group (0.78 + 0.01 mmol/1, range: 0.66-0.88; Table 1 ). Certain animals presented the classic syndrome of magnesium deficiency, characterized by hyperaemia of the skin and hyperexcitability. The initial and final weights in both groups of rats were similar. Serum calcium levels were slightly increased in hypomagnesaemic rats (2.62 + 0.03 vs 2.45 + 0.05 mmol/1, p = NS). The magnesium content correlation between serum magnesium levels and the K index was found in the total group of rats (r = 0.74, p < 0.001). The mean basal serum insulin level was not different between the two groups of rats. After the glucose load, serum insulin levels tended to be lower in the hypomagnesaemic compared with the control rats. The mean post-glucose incremental area of insulin up to 30 min was significantly lower in the hypomagnesaemic rats compared to the control rats (32.3 + 6.2 vs 59.0 _+ 11.0 nmol. 1 -I 9 min, respectively, p < 0.05), and correlated with serum magnesium levels in the total group of rats (r = 0.46, p < 0.05). 
Intravenous glucose tolerance test (IVGTT).
In Table 1 and Figure 1 the results of the IVGTT are shown. Hypomagnesaemic rats presented a significantly (p < 0.05) higher mean basal serum glucose level. After the glucose load, both groups of rats had similar blood glucose values up to 20 min, and thereafter magnesium-deficient rats had a higher (p < 0.05) glycaemia at 30 min. The glucose disappearance rate, calculated as the K index, was reduced by 40% (1.7_+0.1 vs 2.8 _+ 0.2 %/min, p < 0.001) in hypomagnesaemic rats. A significant
Hindquarter perfusion. The data on the glucose uptake by the perfused hindquarters from the two groups of rats are shown in Table 2 . No significant differences in the glucose uptake by the hindquarters were observed between the two groups of rats, although hypomagnesaemic rats had a tendency to have a higher mean basal value and a lower glucose disappearance rate in the presence of all the insulin concentrations assayed. The increments above the basal value of the glucose uptake produced by insulin 5 x 10 -l~ mol/1 and 5 x 10 -9 mol/1 were significantly lower (p < 0.05) in hypomagnesaemic rats compared with control rats, whereas that which was induced by a maximal insulin concentration of 1 x 10 -7 mol/1 was similar in the two groups of rats (Fig. 2) . Compared with control rats, magnesium-deficient rats presented a shift to the right in the insulin response curve, with a significant decrease in the insulin sensitivity as determined by a higher insulin concentration for achieving the half-maximal glucose uptake (EDs0: 0.55 +_ 0.1 vs 1.3+0.3 nmol/1, p < 0,05). A negative correlation between the EDs0 and serum magnesium levels was found in the total group of rats (r = -0.81, p < 0.005).
Insulin binding to purified insulin receptors. The max-
imal specific 125I-insulin binding to partially purified insulin receptors obtained from skeletal muscle and its displacement by increasing concentrations of unlabelled insulin was similar in hypomagnesaemic and control rats (Fig. 3) . The binding affinity calculated as the concentration of unlabelled insulin which was needed to produce a 50 % decrease in insulin binding (IDs0) was similar in both groups of rats (hypomagnesaemic rats 1.9+0.10 vs control rats 1.9 + 0.10 x 10 -9 mol/1). The Scatchard analysis of the binding data showed that the binding capacity of insulin receptors of high and low affinity were unchanged in magnesium-deficient rats.
Insulin receptor tyrosine kinase activity. The tyrosine kinase activity of partially purified insulin receptors from skeletal muscle, determined as the ability to phosphorylate the exogenous substrate Poly Table 2 . Glucose uptake by perfused hindquarters from control and hypomagnesaemic rats Glu4:Tyrl, was found to be significantly reduced in magnesium-deficient rats (Fig. 4) . The kinase activity of insulin receptors from hypomagnesaemic rats was reduced by 30% in the basal state (3.7+0.2 vs 5.3_+0.4pmol for 32p incorporated into Poly Glu4:Tyrl/~tg of receptor protein, p < 0.01) and by 17 % at 10 -7 tool/1 insulin (22.1 _+ 0.9 vs 26.5 + 1.6 pmo132p/~tg of protein, p < 0.05). The increment above the basal value induced by insulin of the receptor kinase activity was also reduced in hypomagnesaemic rats compared with the control group (18.4 + 0.8 vs 21.2 _+ 1.5 pmol 32p/Fg of receptor protein, respectively, p < 0.05). The autophosphorylation of the/3-subunit of insulin receptors from skeletal muscle was greatly impaired in hypomagnesaemic rats (Fig.4) . Insulin receptors from magnesium-deficient rats had a 50 % reduction in their autophosphorylation at basal (0.49 + 0.15 vs 1.03 _+ 0.11 arbitrary units/fmol insulin bound, p < 0.05) and at 10 -7 tool/1 insulin (1.28 + 0.31 vs 2.70 • 0.11 U/fmol insulin bound, p < 0.05). The effect of insulin on the autophosphorylation of the/3-subunit of insulin receptors was therefore also reduced by 50% in hypomagnesaemic rats (0.79 + 0.15 vs 1.67 _+ 0.12 U/fmol insulin bound, p < 0.01). The electrophoretic mobility of the/3-subunit of insulin receptors was similar in hypomagnesaemic and control rats, with a molecular mass of approximately 95 kDa.
Cross-linkage of solubilized insulin receptors with lesI-insulin.
To further characterise the insulin receptor, we determined the electrophoretic mobility of the ct-subunit with the use of the affinity labelling technique. Partially purified insulin receptors were incubated with lasI-insulin and dissuccinimidyl suberate under reducing conditions. A protein with a molecular mass of approximately 135 kDa was labelled, corresponding to the a-subunit of the insulin receptor, and its radioactivity was totally displaced by an excess of unlabelled insulin (10 .7 tool/l), supporting the specificity of insulin binding to this band. The electrophoretic migration of the cross-linked c~-subunit of the insulin receptor was similar in hypomagnesaemic and control rats. In these cross-linking experiments, we used the same amount of protein as in those for 125I-insulin binding, and tyrosine kinase activity experiments.
Glucose transporter protein GLUT 4.
To study the effect of magnesium deficiency on the insulin-sensitive glucose transporter (GLUT 4), Western blot analyses were performed using a polyclonal antisera specific for the carboxyl-terminal peptide of GLUT 4. Figure 5 shows the approximately 45 kDa band corresponding to GLUT 4 obtained by autoradiography, from the gastrocnemius muscles of two control and two hypomagnesaemic rats. The abundance of the glucose transporter protein was quantitated by densimetometry which revealed no significant differences between control (3.55 _+ 0.65 arbitrary units/50 Fg of protein, n = 5) and hypomagnesaemic rats (3.54 + 0.37 U/50 ~g of protein, n = 5).
Discussion
This study was designed in order to reach a better understanding of the mechanism involved in the production of insulin resistance by hypomagnesaemia. We used the experimental model of hypomagnesaemia induced in rats with a diet containing low-Mg +2 for 4 days. This diet produced a reduction of serum Mg +2 levels in all the rats, although the levels ranged from severe to moderate low values.
In order to evaluate the effect of hypomagnesaemia on the in vivo insulin secretion and action, we performed an i.v. glucose load. Hypomagnesaemic rats had high basal glycaemic levels and a low glu- cose disappearance rate; these alterations were associated with normal basal serum insulin levels and a low glucose-stimulated insulin secretion. These data indicate that hypomagnesaemia affects glucose metabolism at different levels; decreasing the ability of pancreatic beta cells to secrete insulin in response to glucose and producing a state of basal insulin resistance. A normal basal insulinaemia and a low glucose-stimulated insulin secretion, after an i.v. or i.p. glucose load, have also been reported in hypomagnesaemic rats [29] [30] [31] . It has been shown that the pancreases from these rats have a low insulin content [29] . The mechanism responsible for the lowering effect of hypomagnesaemia on insulin secretion remains unclear. The possibility of a direct effect of hypomagnesaemia on insulin secretion has been considered, but not demonstrated. In fact, there are contradictory results on the evaluation of the omission of magnesium ion in the medium of pancreas perfusates or in the incubation medium of islets. In these studies either a low insulin synthesis and secretion, an unchanged insulin secretion, or a high insulin secretion have been reported [32] [33] [34] [35] [36] [37] [38] [39] . However, there is a consensus on the inhibitory effect of hypermagnesaemia on insulin secretion. The above, apparently contradictory results have been focused to- exogenous substrate Poly Glu4:Tyrl by WGA-purified muscle insulin receptors from control (1, n = 7) and hypomagnesaemic rats ([~, n : 13), in the absence and presence of 10 -7 mol/1 insulin; data expressed as the amount of pmol of 32p incorporated into exogenous substrate per ~g of receptor protein. * p < 0.05; ** p < 0.01 vs control. B. Autophosphorylation of/3-subunit of muscle insulin receptors from control (n = 5) and hypomagnesaemic rats (n = 5), in the absence and presence of 10 -7 tool/1 insulin. Resuits expressed as arbitrary units per amount of insulin receptor preparation that binds 1 frnol of insulin. *p <0.05; 9 * p < 0.01 vs control group (mean + SEM) wards a theory that an optimal ratio between Ca+2/ Mg +2 in the pancreas is necessary for an adequate insulin secretion. The hypomagnesaemia in rats is usually associated with hypercalcaemia. In our study, hypomagnesaemic rats had only a moderate increase in serum calcium levels. However, it is possible that an imbalance between the two cations could contribute to the altered glucose-stimulated insulin secretion observed in the hypomagnesaemic rats. Another mechanism that has been postulated for the low insulin secretion present in hypomagnesaemic rats is a probable low pancreatic K + content [40] , Although we did not measure the K + content in pancreas or in skeletal muscle, there is evidence of a low K + content in various tissues of hypomagnesaemic rats; i.e. skeletal muscle, liver and heart, in association with either normal or low serum K + levels [41] [42] [43] . Therefore, the independent role of Mg +2 and K + on the impaired glucose-induced insulin secretion in hypomagnesaemia remains to be clarified.
In order to ascertain if insulin resistance, which was evident in the basal situation, could contribute to the decreased glucose disappearance rate after the i.v. glucose load observed in the group of hypomagnesaemic rats, we performed "ex vivo" and "in vitro" studies in skeletal muscle, the major peripheral target tissue of insulin.
In the hindquarter perfusion experiments, magnesium-deficient rats presented a tendency to have a high basal glucose uptake and a low insulin-stimulated glucose utilization, with a 50 % reduction in insulin sensitivity. In spite of a trend towards a higher basal glucose disposal by the hindquarter preparations, hypomagnesaemic rats presented basal hyperglycaemia. This could be due to a high hepatic glucose production related to a more widespread insulin resistance, which also affects the liver. In addition, an increase in the hepatic gluconeogenic enzyme phosphoenolpyruvate carboxykinase has been reported in hypomagnesaemic rats [31] . Our results on basal glucose uptake agree with those of Kahil et al. [44] , showing a high penetration and phosphorylation of 2-deoxyglucose in the intact diaphragm from hypomagnesaemic rats. The effect of hypomagnesaemia on the insulin-stimulated glucose uptake by skeletal muscle has also been previously investigated. In elderly non-insulin-dependent diabetic subjects with a moderate decrease of serum Mg +2 levels, administration of Mg +2 supplements for a month was shown to significantly increase the glucose disposal stimulated by insulin during a euglycaemic hyperinsulinaemic clamp [10] . It has been reported that hypomagnesaemma induced in rats by feeding a high-fructose-containing diet produced a decrease in the submaximal insulin-stimulated glucose uptake by the perfused hindquarters, which could be prevented by supplementing the high-fructose diet with magnesium [45] . The acute effect of hypomagnesaemia was investi-A. Su~rez et al.: Insulin action in hypomagnesaemia gated in soleus muscles from normal rats, depleted of endogenous Mg +2 by pretreatment with EDTAcontaining medium; insulin at the concentration assayed of 0.1 IU/ml was unable to stimulate glucose uptake, but the addition of a low Mg +2 concentration (0.1 mmol/1) to the incubation medium was enough to restore the insulin response [46] . In our study we used a perfusion medium containing a physiological concentration of Mg +2 (1.2mmol/l), thus, under these conditions, the circulating Mg +2 levels were restored. However, the insulin sensitivity for glucose uptake was clearly reduced in the group of magnesium-deficient rats. In these rats we found a moderate decrease in the skeletal muscle content of Mg +2 in comparison with that in the control group. Therefore, magnesium deficiency may cause disturbances in the mechanisms implicated in the insulin-stimulated glucose transport/metabolism, although not high enough to reduce the response to maximal insulin concentrations as was the case in our study and also in the previously-mentioned studies performed in rats fed with a high fructose diet [45] and in normal muscles depleted of Mg +2 [46] .
The first step in insulin action is its binding to specific receptors located at the plasma membrane. Therefore, we studied the insulin binding kinetics to partially-purified solubilized receptors from total homogenates of gastrocnemius muscles. The group of hypomagnesaemic rats had no changes in the displacement curve of 125I-insulin binding to muscle receptors; and both binding affinity and insulin binding capacity were similar to those in the control group. These results agree with those documented by Gould and Chaudry [46] of normal insulin binding to soleus muscles depleted of Mg +2 by pretreatment with EDTA. We have previously reported normal insulin binding to erythrocytes in patients with severe hypomagnesaemia [11] .
In order to ascertain if the structure of the c~-subunit of the insulin receptor would be influenced by magnesium deficiency, we performed insulin-receptor cross-linking experiments under reducing conditions. In this study a normal displacement of 12sI-insulin by unlabelled insulin to its binding to the (x-subunit of receptor was found again. The c~-subunit of the muscle insulin receptor from hypomagnesaemic rats had a similar electrophoretic mobility to that in the control rats, with a molecular mass of -135 kDa.
Once insulin is bound to its receptor, an immediate activation of the tyrosine kinase present in the/3-subunit of the insulin receptor takes place. This reaction is considered to be the first signalling mechanism of insulin action. The activation of the receptor tyrosine kinase produces the phosphorylation in tyrosine residues of its own/3-subunit of the receptor (autophosphorylation) as well as the tyrosine phosphorylation of intracellular substrates or exogenous substrates. Therefore, we decided to determine if magnesium deficiency would alter the enzymatic activity of the muscle insulin receptors. The group of hypomagnesaemic rats presented a significant reduction in both basal and insulin-stimulated insulin receptor tyrosine kinase activity, determined as the ability to phosphorylate its own fi-subunit as well as the exogenous substrate Poly Glu4:Tyrl. The insulin receptor kinase activity from Mg+2-deficient rats was more defective in inducing the autophosphorylation of the/3-subunit; the increment above the basal value of the autophosphorylation induced by insulin represented 50 % of the control, whereas the increment of the phosphorylation of Poly Glu4:Tyrl represented 80 % of the control. It is important to understand that these results were obtained from in vitro studies and that these experiments were performed in the presence of optimal concentrations of Mg +2. Therefore, it is possible that the receptor kinase disturbance will become worse in the intact situation of hypomagnesaemia. The defective autophosphorylation of the fi-subunit of muscle insulin receptors from hypomagnesaemic rats could not be attributed to major changes in the structure of the/3-subunit, as the electrophoretic mobility of the subunit was identical to that in the control group, with an apparent molecular mass of 95 kDa.
Glucose transport is mediated by a family of glucose transporter isoforms with distinct structure, function and tissue distribution [47] [48] [49] . Skeletal muscle expresses the isoforms GLUT 1 and GLUT 4. GLUT 1 mediates the glucose uptake in the basal situation, whereas GLUT 4, which is specific for adipose and skeletal muscle tissues, is responsible for insulin-stimulated glucose transport. In order to see if hypomagnesaemia would influence the expression of the GLUT 4 protein, we measured it in solubilized homogenates of gastrocnemius muscles. No differences in the total GLUT 4 content of skeletal muscle were found between magnesium-deficient rats and control rats. However, further studies are required in order to know if hypomagnesaemia alters the activation/translocation of the GLUT 4, as those mechanisms need to be intact for an adequate insulin-stimulated glucose transport.
The relationship between magnesium and diabetes mellitus has attracted greater interest in recent years. The results of our work clearly demonstrate that magnesium deficiency produces a deleterious effect on glucose handling which seems to be due to both a decrease in insulin secretion and sensitivity. A deficient magnesium intake is a risk factor for the development of non-insulin-dependent diabetes in women [50] . Furthermore, there is evidence of a preventive role of dietary magnesium supplementation in the development of spontaneous type 2 diabetes in rats [51] .
Although the mechanism by which the insulin secretion was impaired in hypomagnesaemic rats needs further clarification, the low insulin sensitivity observed in these rats may be attributed, at least in part, to a defective tyrosine kinase activity of muscle insulin receptors.
